The Department of Chemical Engineering is pleased to announce that Professor Ruibing Wang will join the faculty in April 2027.
Wang's research spans nanomaterials, pharmaceutics, radiopharmaceuticals, supramolecular biomaterials and cell-based therapeutics. His work focuses on engineering cells and nanomedicines to target cardiovascular and inflammatory diseases, cancer and damaged tissues.
He has developed approaches to targeted therapy that use functionally engineered cells to deliver treatments directly to diseased tissue. His research also explores the use of microalgae, cells and bacteria as vehicles for delivering therapeutics to tumours and injured tissues.
Wang earned his PhD from Queen's University and is recognized among Stanford University's World's Top 2% Scientists.